https://medicaldialogues.in/news/industry/pharma/reduce-psa-level-to-less-than-4-in-inclusion-criteria-cdsco-panel-tells-akum-drugs-and-pharmaceuticals-on-fdc-dutasteride-plus-silodosin-127345